Targeting FoxO proteins induces lytic reactivation of KSHV for treating herpesviral primary effusion lymphoma. Lan J, Wang Y, Yue S, Xu D, et al. PLoS Pathog 2023;19:e1011581.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lan J, Wang Y, Yue S, Xu D, et al. Targeting FoxO proteins induces lytic reactivation of KSHV for treating herpesviral primary effusion lymphoma. PLoS Pathog 2023;19:e1011581.
PMID: 37594999